Skip to main content
. 2020 Aug 13;10:13753. doi: 10.1038/s41598-020-70742-3

Table 1.

Baseline patient characteristics (continuous variables expressed as median (IQR)). *BMI = Body Mass Index; PPI = Proton Pump Inhibitors; §GERD-HRQL = Gastro-Esophageal Reflux Disease Health Related Quality of Life; LESP = Lower Esophageal Sphincter Pressure; DEA = Distal Esophageal Amplitude; δIEM = Ineffective esophageal motility.

F.U. < 6 years (n = 211) F.U. 6–12 years (n = 124)
Age, years 46 (20) 44 (20.8)
Male, n (%) 139 (65.8) 83 (66.9)
BMI*, kg/m2 25.4 (5) 23.9 (4.5)
Duration of symptoms, years 8 (11.3) 6 (7)
PPI use, years 7 (7) 4 (6)
GERD-HRQL§ total score 19.5 (10) 21 (9.5)
Esophagitis, n (%)
None 167 (79.1) 103 (83.1)
Grade A 22 (10.4) 11 (8.9)
Grade B 18 (8.5) 9 (7.2)
Grade C 2 (1.0) 1 (0.8)
Grade D 2 (1.0) 0 (0.0)
Barrett’s esophagus, n (%) 10 (4.7) 4 (3.2)
Hiatal hernia length, n (%)
None 57 (27.0) 18 (14.5)
1 cm 24 (11.4) 37 (29.8)
2 cm 70 (33.2) 44 (35.6)
3 cm 35 (16.6) 20 (16.1)
≥ 4 cm 25 (11.8) 5 (4.0)
Basal LESP, mmHg 14.2 (15.4) 15.1 (12)
DEA※, mmHg 66 (40) 63.0 (34.2)
IEMδ, n (%) 19 (9.0) 1 (0.8)
DeMeester score 24.8 (26.8) 31.3 (24.6)
% total time pH < 4 6.4 (6.8) 8 (6.6)